Stay updated on Bispecific Antibody MCLA-158 Clinical Trial

Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5 on the page. This appears to be a minor metadata/patch update and does not change study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-11T21:48:56.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page adds details about new expansion cohorts and dosing (RP2D of 1500 mg every 2 weeks for single-agent MCLA-158) and outlines planned combination cohorts with pembrolizumab, FOLFIRI, and FOLFOX. It also updates recruitment sites, investigators, and contact information across many locations.
    Difference
    6%
    Check dated 2026-08-04T17:33:51.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page, signaling a minor update to the study details page. No substantive study data or user-visible content appears to be changed.
    Difference
    0.0%
    Check dated 2026-07-28T15:13:57.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    - Page revision updated from v3.6.0 to v3.6.3, indicating a new build/version of the page rather than a change to the study content. This is a metadata-level update visible on the page.
    Difference
    0.0%
    Check dated 2026-06-30T01:07:42.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    New navigation/help sections such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study were added, improving access to participation and information. The Intervention/Treatment heading formatting was updated (from 'Intervention / Treatment' to 'Intervention/Treatment'), and the footer revision label now shows Revision: v3.6.0, replacing the previous v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-15T18:11:24.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.5.4 to v3.5.5. This indicates a new version of the page with minor edits or fixes.
    Difference
    0.0%
    Check dated 2026-06-08T15:20:17.000Z thumbnail image

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.